#EXP00014

General

Accession EXP00014
Activity Preformed biofilm
Date 2013-11-10
Administration In solution
Model in vitro
Organism Stenotrophomonas maltophilia
Status Validated
Notes Sm109 clinical isolate

Peptide

BMAP-27

GRFKRFRKKFKKLFKKLSPVIPLLHL

Experimental activity

Method Concentration Notes
Total countable CFUs 2.481 uM No notes
Total countable CFUs 4.963 uM No notes

References

Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura

2011. Peptides 9:1807-1814